# A Study of HC006 in Subjects With Advanced Solid Tumors

> **NCT06304571** · PHASE1 · RECRUITING · sponsor: **HC Biopharma Inc.** · enrollment: 76 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** HC006

## Key facts

- **NCT ID:** NCT06304571
- **Lead sponsor:** HC Biopharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-27
- **Primary completion:** 2026-03-15
- **Final completion:** 2026-07-16
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06304571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06304571, "A Study of HC006 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06304571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*